Mylan Plans Launch Of Generic Duragesic Despite Pediatric Exclusivity

Mylan is planning to launch its generic fentanyl transdermal system by July, the date of the original patent expiration for Alza's Duragesic, despite the product's six-month pediatric exclusivity extension

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet